Cargando…

Multiple Biomarker Prediction of Type 2 Diabetes

Detalles Bibliográficos
Autor principal:	Meigs, James B.
Formato:	Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2009
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2699735/ https://www.ncbi.nlm.nih.gov/pubmed/19564478 http://dx.doi.org/10.2337/dc09-0754

Ejemplares similares

Genetic risk profiling for prediction of type 2 diabetes
por: Mihaescu, Raluca, et al.
Publicado: (2011)

Does Diabetes Always Confer Coronary Heart Disease Risk Equivalent to a Prior Myocardial Infarction?: Implications for prevention
por: Boyko, Edward J., et al.
Publicado: (2011)

Postprandial insulin assay as the earliest biomarker for diagnosing pre-diabetes, type 2 diabetes and increased cardiovascular risk
por: DiNicolantonio, James J, et al.
Publicado: (2017)

Epidemiology of Type 2 Diabetes and Cardiovascular Disease: Translation From Population to Prevention: The Kelly West Award Lecture 2009
por: Meigs, James B.
Publicado: (2010)

Response to Comment on Vassy et al. Polygenic Type 2 Diabetes Prediction at the Limit of Common Variant Detection. Diabetes 2014;63:2172–2182
por: Vassy, Jason L., et al.
Publicado: (2014)

Nutritional Biomarkers, Gene-Diet Interaction, and Risk Factors for Type 2 Diabetes
por: Zheng, Ju-Sheng, et al.
Publicado: (2016)

Diabetes Genetic Predisposition Score and Cardiovascular Complications Among Patients With Type 2 Diabetes
por: Qi, Qibin, et al.
Publicado: (2013)

Prediction of Type 2 Diabetes by Hemoglobin A(1c) in Two Community-Based Cohorts
por: Leong, Aaron, et al.
Publicado: (2018)

Polygenic Type 2 Diabetes Prediction at the Limit of Common Variant Detection
por: Vassy, Jason L., et al.
Publicado: (2014)

Is GDF15 a Novel Biomarker to Predict the Development of Prediabetes or Diabetes?
por: Hur, Kyu Yeon
Publicado: (2014)

Erratum. Polygenic Type 2 Diabetes Prediction at the Limit of Common Variant Detection. Diabetes 2014;63:2172–2182
por: Vassy, Jason L., et al.
Publicado: (2018)

Serum Cystatin C as a Biomarker for Predicting Coronary Artery Disease in Diabetes
por: Oh, Jee-Young
Publicado: (2010)

Diabetic Microvascular Complications: Novel Risk Factors, Biomarkers, and Risk Prediction Models
por: McKay, Gareth J., et al.
Publicado: (2016)

Higher Dietary Flavonol Intake Is Associated with Lower Incidence of Type 2 Diabetes(1)(2)
por: Jacques, Paul F., et al.
Publicado: (2013)

Multiple Biomarkers Improved Prediction for the Risk of Type 2 Diabetes Mellitus in Singapore Chinese Men and Women
por: Wang, Yeli, et al.
Publicado: (2020)

Metabolite Traits and Genetic Risk Provide Complementary Information for the Prediction of Future Type 2 Diabetes
por: Walford, Geoffrey A., et al.
Publicado: (2014)

The Promising Biomarker for Multiple Clinical Situations
por: Sadeghi, Mohammad Reza
Publicado: (2014)

Biomarkers for predicting type 2 diabetes development—Can metabolomics improve on existing biomarkers?
por: Savolainen, Otto, et al.
Publicado: (2017)

Misdiagnosis of type 1 and type 2 diabetes in adults
por: The Lancet Regional Health – Europe
Publicado: (2023)

Metformin and Cancer in Type 2 Diabetes
por: Park, Hyeong Kyu
Publicado: (2013)

Dietary Intake and Type 2 Diabetes
por: Ojo, Omorogieva
Publicado: (2019)

Commentary on "Single point insulin sensitivity estimator for predicting type 2 diabetes mellitus in obese adolescents"
por: Kim, Shin-Hye
Publicado: (2022)

Cancer Diagnostic and Predictive Biomarkers
por: Buonaguro, Franco M., et al.
Publicado: (2014)

“Prediction Is Very Hard, Especially About the Future”: New Biomarkers for Type 2 Diabetes?
por: Lowe, William L., et al.
Publicado: (2013)

When and how to use predictive biomarkers for corticosteroid treatment of septic shock
por: Russell, James A.
Publicado: (2018)

Experimental Models of Type-2 Diabetic Nephropathy
por: Tomino, Yasuhiko, et al.
Publicado: (2012)

Type 2 Diabetes and Cardiovascular Risk in Women
por: Russo, Giuseppina T., et al.
Publicado: (2015)

Sulfonylurea: Personalized Medicine for Type 2 Diabetes
por: Hwang, You-Cheol
Publicado: (2015)

Genomics and Metabolomics in Obesity and Type 2 Diabetes
por: Kretowski, Adam, et al.
Publicado: (2016)

Type 2 Diabetes Mellitus and Macrovascular Complications
por: Shan, Peng-Fei, et al.
Publicado: (2017)

Depression and Mortality in Type 2 Diabetes Mellitus
por: Lee, Seo Young, et al.
Publicado: (2017)

Osteoporosis and Fragility Fractures in Type 2 Diabetes
por: Chiodini, Iacopo, et al.
Publicado: (2020)

β-cell senescence in type 2 diabetes
por: Aguayo-Mazzucato, Cristina, et al.
Publicado: (2019)

Nutrients and Cardiometabolic Health in Type 2 Diabetes
por: Tricò, Domenico
Publicado: (2023)

Comparison of non-traditional biomarkers, and combinations of biomarkers, for vascular risk prediction in people with type 2 diabetes: The Edinburgh Type 2 Diabetes Study
por: Price, Anna H., et al.
Publicado: (2017)

Early Glycosylated Hemoglobin Target Achievement Predicts Clinical Outcomes in Patients with Newly Diagnosed Type 2 Diabetes Mellitus
por: Lee, Joonyub, et al.
Publicado: (2021)

Biomarkers for type 2 diabetes
por: Laakso, Markku
Publicado: (2019)

Cancer Diagnostic and Predictive Biomarkers 2015
por: Buonaguro, Franco M., et al.
Publicado: (2015)

TAS-102 and the quest for predictive biomarkers
por: van der Velden, Daphne L, et al.
Publicado: (2017)

Cancer Diagnostic and Predictive Biomarkers 2018
por: Buonaguro, Franco M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0lkrn1e5qq0m1csg9k7kiancpg